Status:

COMPLETED

Comparison of the Efficacy of 0.5% Bupivacaine, 0.5% Levobupivacaine, and 0.5% Hyperbaric Bupivacaine

Lead Sponsor:

Mogilev Regional Clinical Hospital

Conditions:

Anesthesia, Spinal

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

About 15 million spinal anesthesia procedures are performed worldwide each year. In the daily practice of the anesthesiologist for intrathecal use there are various local anesthetics such as bupivacai...

Detailed Description

111patients who underwent surgical intervention on the hip, thigh, and knee joints were included in the study. Criteria for inclusion of patients in the study: indications for surgical intervention o...

Eligibility Criteria

Inclusion

  • indications for surgical intervention on the hip, thigh, and knee joints

Exclusion

  • patient refusal to use the proposed type of anesthesia,
  • age \<18 years,
  • body mass index not \> 39,
  • physical status according to ASA 1-3,
  • history of allergic reactions to the drugs used,
  • coagulopathy,
  • infectious skin lesions in the injection area,
  • neurological or neuromuscular diseases,
  • severe liver disease or renal failure,
  • inability to cooperate with the patient.

Key Trial Info

Start Date :

December 18 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 6 2022

Estimated Enrollment :

111 Patients enrolled

Trial Details

Trial ID

NCT05184465

Start Date

December 18 2017

End Date

January 6 2022

Last Update

January 11 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Mogilev Regional Clinical Hospital

Mogilev, Belarus, 212026

Comparison of the Efficacy of 0.5% Bupivacaine, 0.5% Levobupivacaine, and 0.5% Hyperbaric Bupivacaine | DecenTrialz